From	O
Homology	B:C1512489
Models	I:C1512489
to	O
a	O
Set	O
of	O
Predictive	O
Binding	O
Pockets	I:C0005456
-a	O
5	O
-	I:C0379900
HT1A	I:C0379900
Receptor	I:C0379900
Case	O
Study	I:C2603343
.	O

From	O
Homology	O
Models	I:C1512489
to	O
a	O
Set	O
of	O
Predictive	O
Binding	B:C0005456
Pockets	I:C0005456
-a	O
5	O
-	I:C0379900
HT1A	I:C0379900
Receptor	I:C0379900
Case	O
Study	I:C2603343
.	O

From	O
Homology	O
Models	I:C1512489
to	O
a	O
Set	O
of	O
Predictive	O
Binding	O
Pockets	I:C0005456
-a	O
5	B:C0379900
-	I:C0379900
HT1A	I:C0379900
Receptor	I:C0379900
Case	O
Study	I:C2603343
.	O

From	O
Homology	O
Models	I:C1512489
to	O
a	O
Set	O
of	O
Predictive	O
Binding	O
Pockets	I:C0005456
-a	O
5	O
-	I:C0379900
HT1A	I:C0379900
Receptor	I:C0379900
Case	B:C2603343
Study	I:C2603343
.	O

Despite	O
its	O
remarkable	O
importance	O
in	O
the	O
arena	O
of	O
drug	O
design	O
,	O
serotonin	B:C0379900
1A	I:C0379900
receptor	I:C0379900
(	O
5	O
-	I:C0379900
HT1A	I:C0379900
)	O
has	O
been	O
elusive	O
to	O
the	O
X	O
-	I:C0206755
ray	I:C0206755
crystallography	I:C0206755
community	O
.	O

Despite	O
its	O
remarkable	O
importance	O
in	O
the	O
arena	O
of	O
drug	O
design	O
,	O
serotonin	O
1A	I:C0379900
receptor	I:C0379900
(	O
5	B:C0379900
-	I:C0379900
HT1A	I:C0379900
)	O
has	O
been	O
elusive	O
to	O
the	O
X	O
-	I:C0206755
ray	I:C0206755
crystallography	I:C0206755
community	O
.	O

Despite	O
its	O
remarkable	O
importance	O
in	O
the	O
arena	O
of	O
drug	O
design	O
,	O
serotonin	O
1A	I:C0379900
receptor	I:C0379900
(	O
5	O
-	I:C0379900
HT1A	I:C0379900
)	O
has	O
been	O
elusive	O
to	O
the	O
X	B:C0206755
-	I:C0206755
ray	I:C0206755
crystallography	I:C0206755
community	O
.	O

This	O
lack	O
of	O
direct	O
structural	B:C0678594
information	O
not	O
only	O
hampers	O
our	O
knowledge	O
regarding	O
the	O
binding	O
modes	I:C1167622
of	O
many	O
popular	O
ligands	O
(	O
including	O
the	O
endogenous	O
neurotransmitter	O
-	O
serotonin	O
)	O
,	O
but	O
also	O
limits	O
the	O
search	O
for	O
more	O
potent	O
compounds	O
.	O

This	O
lack	O
of	O
direct	O
structural	O
information	O
not	O
only	O
hampers	O
our	O
knowledge	O
regarding	O
the	O
binding	B:C1167622
modes	I:C1167622
of	O
many	O
popular	O
ligands	O
(	O
including	O
the	O
endogenous	O
neurotransmitter	O
-	O
serotonin	O
)	O
,	O
but	O
also	O
limits	O
the	O
search	O
for	O
more	O
potent	O
compounds	O
.	O

This	O
lack	O
of	O
direct	O
structural	O
information	O
not	O
only	O
hampers	O
our	O
knowledge	O
regarding	O
the	O
binding	O
modes	I:C1167622
of	O
many	O
popular	O
ligands	B:C0023688
(	O
including	O
the	O
endogenous	O
neurotransmitter	O
-	O
serotonin	O
)	O
,	O
but	O
also	O
limits	O
the	O
search	O
for	O
more	O
potent	O
compounds	O
.	O

This	O
lack	O
of	O
direct	O
structural	O
information	O
not	O
only	O
hampers	O
our	O
knowledge	O
regarding	O
the	O
binding	O
modes	I:C1167622
of	O
many	O
popular	O
ligands	O
(	O
including	O
the	O
endogenous	O
neurotransmitter	B:C0027908
-	O
serotonin	O
)	O
,	O
but	O
also	O
limits	O
the	O
search	O
for	O
more	O
potent	O
compounds	O
.	O

This	O
lack	O
of	O
direct	O
structural	O
information	O
not	O
only	O
hampers	O
our	O
knowledge	O
regarding	O
the	O
binding	O
modes	I:C1167622
of	O
many	O
popular	O
ligands	O
(	O
including	O
the	O
endogenous	O
neurotransmitter	O
-	O
serotonin	B:C0036751
)	O
,	O
but	O
also	O
limits	O
the	O
search	O
for	O
more	O
potent	O
compounds	O
.	O

This	O
lack	O
of	O
direct	O
structural	O
information	O
not	O
only	O
hampers	O
our	O
knowledge	O
regarding	O
the	O
binding	O
modes	I:C1167622
of	O
many	O
popular	O
ligands	O
(	O
including	O
the	O
endogenous	O
neurotransmitter	O
-	O
serotonin	O
)	O
,	O
but	O
also	O
limits	O
the	O
search	O
for	O
more	O
potent	O
compounds	B:C1706082
.	O

In	O
this	O
paper	O
we	O
shed	O
new	O
light	O
on	O
the	O
3D	B:C0450363
pharmacological	O
properties	O
of	O
the	O
5	O
-	I:C0379900
HT1A	I:C0379900
receptor	I:C0379900
by	O
using	O
a	O
ligand	O
-	O
guided	O
approach	O
(	O
ALiBERO	O
)	O
grounded	O
in	O
the	O
Internal	O
Coordinate	I:C0037585
Mechanics	I:C0037585
(	O
Internal	O
Coordinate	I:C0037585
Mechanics	I:C0037585
)	O
docking	O
platform	O
.	O

In	O
this	O
paper	O
we	O
shed	O
new	O
light	O
on	O
the	O
3D	O
pharmacological	O
properties	O
of	O
the	O
5	B:C0379900
-	I:C0379900
HT1A	I:C0379900
receptor	I:C0379900
by	O
using	O
a	O
ligand	O
-	O
guided	O
approach	O
(	O
ALiBERO	O
)	O
grounded	O
in	O
the	O
Internal	O
Coordinate	I:C0037585
Mechanics	I:C0037585
(	O
Internal	O
Coordinate	I:C0037585
Mechanics	I:C0037585
)	O
docking	O
platform	O
.	O

In	O
this	O
paper	O
we	O
shed	O
new	O
light	O
on	O
the	O
3D	O
pharmacological	O
properties	O
of	O
the	O
5	O
-	I:C0379900
HT1A	I:C0379900
receptor	I:C0379900
by	O
using	O
a	O
ligand	O
-	O
guided	O
approach	O
(	O
ALiBERO	O
)	O
grounded	O
in	O
the	O
Internal	B:C0037585
Coordinate	I:C0037585
Mechanics	I:C0037585
(	O
Internal	O
Coordinate	I:C0037585
Mechanics	I:C0037585
)	O
docking	O
platform	O
.	O

In	O
this	O
paper	O
we	O
shed	O
new	O
light	O
on	O
the	O
3D	O
pharmacological	O
properties	O
of	O
the	O
5	O
-	I:C0379900
HT1A	I:C0379900
receptor	I:C0379900
by	O
using	O
a	O
ligand	O
-	O
guided	O
approach	O
(	O
ALiBERO	O
)	O
grounded	O
in	O
the	O
Internal	O
Coordinate	I:C0037585
Mechanics	I:C0037585
(	O
Internal	B:C0037585
Coordinate	I:C0037585
Mechanics	I:C0037585
)	O
docking	O
platform	O
.	O

In	O
this	O
paper	O
we	O
shed	O
new	O
light	O
on	O
the	O
3D	O
pharmacological	O
properties	O
of	O
the	O
5	O
-	I:C0379900
HT1A	I:C0379900
receptor	I:C0379900
by	O
using	O
a	O
ligand	O
-	O
guided	O
approach	O
(	O
ALiBERO	O
)	O
grounded	O
in	O
the	O
Internal	O
Coordinate	I:C0037585
Mechanics	I:C0037585
(	O
Internal	O
Coordinate	I:C0037585
Mechanics	I:C0037585
)	O
docking	B:C1522290
platform	O
.	O

Starting	O
from	O
a	O
homology	O
template	O
and	O
set	O
of	O
known	O
actives	O
,	O
the	O
method	O
introduces	O
receptor	B:C0597357
flexibility	O
via	O
Normal	O
Mode	I:C0936012
Analysis	I:C0936012
and	O
Monte	O
Carlo	O
sampling	O
,	O
to	O
generate	O
a	O
subset	O
of	O
pockets	O
that	O
display	O
enriched	O
discrimination	O
of	O
actives	O
from	O
inactives	O
in	O
retrospective	O
docking	O
.	O

Starting	O
from	O
a	O
homology	O
template	O
and	O
set	O
of	O
known	O
actives	O
,	O
the	O
method	O
introduces	O
receptor	O
flexibility	O
via	O
Normal	B:C0936012
Mode	I:C0936012
Analysis	I:C0936012
and	O
Monte	O
Carlo	O
sampling	O
,	O
to	O
generate	O
a	O
subset	O
of	O
pockets	O
that	O
display	O
enriched	O
discrimination	O
of	O
actives	O
from	O
inactives	O
in	O
retrospective	O
docking	O
.	O

Starting	O
from	O
a	O
homology	O
template	O
and	O
set	O
of	O
known	O
actives	O
,	O
the	O
method	O
introduces	O
receptor	O
flexibility	O
via	O
Normal	O
Mode	I:C0936012
Analysis	I:C0936012
and	O
Monte	O
Carlo	O
sampling	O
,	O
to	O
generate	O
a	O
subset	O
of	O
pockets	B:C0005456
that	O
display	O
enriched	O
discrimination	O
of	O
actives	O
from	O
inactives	O
in	O
retrospective	O
docking	O
.	O

Starting	O
from	O
a	O
homology	O
template	O
and	O
set	O
of	O
known	O
actives	O
,	O
the	O
method	O
introduces	O
receptor	O
flexibility	O
via	O
Normal	O
Mode	I:C0936012
Analysis	I:C0936012
and	O
Monte	O
Carlo	O
sampling	O
,	O
to	O
generate	O
a	O
subset	O
of	O
pockets	O
that	O
display	O
enriched	O
discrimination	O
of	O
actives	O
from	O
inactives	O
in	O
retrospective	O
docking	B:C1522290
.	O

Here	O
,	O
we	O
thoroughly	O
investigated	O
the	O
repercussions	O
of	O
using	O
different	O
protein	O
templates	O
and	O
the	O
effect	O
of	O
compound	B:C1706082
selection	O
on	O
screening	O
performance	O
.	O

Finally	O
,	O
the	O
best	O
resulting	O
protein	O
models	O
were	O
applied	O
prospectively	O
in	O
a	O
large	O
virtual	O
screening	O
campaign	O
,	O
in	O
which	O
two	O
new	O
active	O
compounds	B:C1706082
were	O
identified	O
that	O
were	O
chemically	O
distinct	O
from	O
those	O
described	O
in	O
the	O
literature	O
.	O

Finally	O
,	O
the	O
best	O
resulting	O
protein	O
models	O
were	O
applied	O
prospectively	O
in	O
a	O
large	O
virtual	O
screening	O
campaign	O
,	O
in	O
which	O
two	O
new	O
active	O
compounds	O
were	O
identified	O
that	O
were	O
chemically	O
distinct	O
from	O
those	O
described	O
in	O
the	O
literature	B:C0023866
.	O

